Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2012-07-31
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of a Oral Endotracheal Tube Fastener on Patients Intubated With Oral Endotracheal Tubes
NCT02760927
A Clinical Comparison of Two Marketed Skin Barriers on Healthy Volunteers
NCT01534039
Effectiveness Study of the BOA(R)-Constricting IV Band
NCT01104103
ElastoMeric Infusion Pumps for Hospital AntibioTICs
NCT05150015
Safety of the PET-512MC Transesophageal Transducer
NCT01186380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Endotracheal (ET) tube securement device
Single arm study evaluated an experimental ET tube securement device with a bite block.
Experimental ET Tube Securement Device
Experimental Hollister device with bite block was substituted for standard-of-care device during the study period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental ET Tube Securement Device
Experimental Hollister device with bite block was substituted for standard-of-care device during the study period.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has intact skin on application site.
* Willingly signs or their authorized representative willingly signs the Informed Consent.
* Is qualified to participate in the opinion of the Investigator.
Exclusion Criteria
* Has protruding upper teeth, without teeth or is unable to wear upper dentures.
* Has facial hair.
* Has clinically significant skin diseases on the application site which may contraindicate participation, including psoriasis, eczema, atopic dermatitis, active cancer.
* Has damaged skin or conditions on the application site which includes sunburn, scars, moles or other disfiguration of the test site.
* Has a known or stated allergy to adhesive bandages, or any of the product types being tested.
* Uses of topical drugs on the application site.
* Uses lotions, creams or oils on the application site.
* Currently is participating in any clinical testing which may affect performance of this device.
* Has been previously intubated with skin irritation or pressure sores surrounding the mouth.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hollister Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elizabeth Konz, PhD
Role: STUDY_CHAIR
Hollister Incorporated
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hartford Hospital
Hartford, Connecticut, United States
Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
St. Joseph's Hospitals
Tampa, Florida, United States
Legacy Good Samaritan
Portland, Oregon, United States
Legacy Salmon Creek Medical Center
Vancouver, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5156-I
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.